BRIEF published on 04/23/2024 at 09:00, 2 years ago BiLendi Announces 2024 Financial Calendar Financial Calendar Bilendi Corporate Transparency 2024 Financial Dates Earnings Disclosure
BRIEF published on 04/23/2024 at 09:00, 2 years ago METAVISIO signs a distribution agreement with PEOPLE in China Distribution Agreement Chinese Market Technological Innovation International Expansion Metavisio
BRIEF published on 04/23/2024 at 08:35, 2 years ago Cie du Bois Sauvage Reports Weekly Share Buyback Activity Cie Du Bois Sauvage Share Buyback Corporate Finance Stock Market Euronext Brussels
BRIEF published on 04/23/2024 at 08:35, 2 years ago Strengthening Governance at AST Groupe Governance Chief Operating Officer Restructuring AST GROUP Individual Houses
BRIEF published on 04/23/2024 at 08:35, 2 years ago CYBERGUN is considering the sale of its Civil division to refocus on the Military Share Price Transfer Strategic Refocusing CYBERGUN Civil Division
BRIEF published on 04/23/2024 at 08:05, 2 years ago OHB SE Reports Significant Growth in 2023 Financial Results Dividend OHB SE Earnings Increase Financial Growth SPACE SYSTEMS
BRIEF published on 04/23/2024 at 08:05, 2 years ago Mayr-Melnhof Karton AG Reports Modest First Quarter 2024 Financial Results Market Challenges Mayr-Melnhof Karton AG Q1 2024 Financial Results Volume Growth Margins Pressure
BRIEF published on 04/23/2024 at 08:05, 2 years ago Defence’s ARM-002 Shows Promise in Advanced Melanoma Treatment Melanoma Treatment Defence Therapeutics AccuTOX Technology Immune-oncology ARM-002 Vaccine
BRIEF published on 04/23/2024 at 08:05, 2 years ago Molten Ventures Plc Announces Full Year Trading Update and Future Outlook Financial Results Investment Strategy Venture Capital Molten Ventures Market Outlook
BRIEF published on 04/23/2024 at 08:05, 2 years ago Berlin Cures Completes Screening Phase of BC 007 Trial in Fight Against Long COVID Clinical Research Berlin Cures Phase II Trial BC 007 Long COVID Treatment
Published on 05/09/2026 at 00:00, 30 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:00, 1 hour 30 minutes ago Digi Power X Announces Upsizing of At-the-Market Offering Program
Published on 05/08/2026 at 22:30, 2 hours ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
Published on 05/08/2026 at 22:30, 2 hours ago Sekur Private Data Advances Defense-Grade Secure Communications Platform
Published on 05/08/2026 at 20:38, 3 hours 52 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 5 hours 17 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 5 hours 28 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 5 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 5 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 6 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 1 day 6 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
